118 related articles for article (PubMed ID: 26217727)
21. Analyzing Cerebrospinal Fluid Proteomes to Characterize Central Nervous System Disorders: A Highly Automated Mass Spectrometry-Based Pipeline for Biomarker Discovery.
Núñez Galindo A; Macron C; Cominetti O; Dayon L
Methods Mol Biol; 2019; 1959():89-112. PubMed ID: 30852817
[TBL] [Abstract][Full Text] [Related]
22. Proteomics analysis of prefractionated human lumbar cerebrospinal fluid.
Yuan X; Desiderio DM
Proteomics; 2005 Feb; 5(2):541-50. PubMed ID: 15627968
[TBL] [Abstract][Full Text] [Related]
23. Insights into the human brain proteome: Disclosing the biological meaning of protein networks in cerebrospinal fluid.
Bastos P; Ferreira R; Manadas B; Moreira PI; Vitorino R
Crit Rev Clin Lab Sci; 2017 May; 54(3):185-204. PubMed ID: 28393582
[TBL] [Abstract][Full Text] [Related]
24. A Versatile Workflow for Cerebrospinal Fluid Proteomic Analysis with Mass Spectrometry: A Matter of Choice between Deep Coverage and Sample Throughput.
Macron C; Núñez Galindo A; Cominetti O; Dayon L
Methods Mol Biol; 2019; 2044():129-154. PubMed ID: 31432411
[TBL] [Abstract][Full Text] [Related]
25. Effects of blood contamination and the rostro-caudal gradient on the human cerebrospinal fluid proteome.
Aasebø E; Opsahl JA; Bjørlykke Y; Myhr KM; Kroksveen AC; Berven FS
PLoS One; 2014; 9(3):e90429. PubMed ID: 24599184
[TBL] [Abstract][Full Text] [Related]
26. Proteomics analysis of human cerebrospinal fluid.
Yuan X; Desiderio DM
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):179-89. PubMed ID: 15652808
[TBL] [Abstract][Full Text] [Related]
27. Characterization of Cerebrospinal Fluid via Data-Independent Acquisition Mass Spectrometry.
Barkovits K; Linden A; Galozzi S; Schilde L; Pacharra S; Mollenhauer B; Stoepel N; Steinbach S; May C; Uszkoreit J; Eisenacher M; Marcus K
J Proteome Res; 2018 Oct; 17(10):3418-3430. PubMed ID: 30207155
[TBL] [Abstract][Full Text] [Related]
28. Autoantibody profiling on human proteome microarray for biomarker discovery in cerebrospinal fluid and sera of neuropsychiatric lupus.
Hu C; Huang W; Chen H; Song G; Li P; Shan Q; Zhang X; Zhang F; Zhu H; Wu L; Li Y
PLoS One; 2015; 10(5):e0126643. PubMed ID: 25954975
[TBL] [Abstract][Full Text] [Related]
29. Determination of Cerebrospinal Fluid Proteome Variations by Isobaric Labeling Coupled with Strong Cation-Exchange Chromatography and Tandem Mass Spectrometry.
Lachén-Montes M; González-Morales A; Fernández-Irigoyen J; Santamaría E
Methods Mol Biol; 2019; 2044():155-168. PubMed ID: 31432412
[TBL] [Abstract][Full Text] [Related]
30. Enhanced detection of CNS cell secretome in plasma protein-depleted cerebrospinal fluid.
Thouvenot E; Urbach S; Dantec C; Poncet J; Séveno M; Demettre E; Jouin P; Touchon J; Bockaert J; Marin P
J Proteome Res; 2008 Oct; 7(10):4409-21. PubMed ID: 18774838
[TBL] [Abstract][Full Text] [Related]
31. Proteomes of Paired Human Cerebrospinal Fluid and Plasma: Relation to Blood-Brain Barrier Permeability in Older Adults.
Dayon L; Cominetti O; Wojcik J; Galindo AN; Oikonomidi A; Henry H; Migliavacca E; Kussmann M; Bowman GL; Popp J
J Proteome Res; 2019 Mar; 18(3):1162-1174. PubMed ID: 30702894
[TBL] [Abstract][Full Text] [Related]
32. Deployment of Label-Free Quantitative Olfactory Proteomics to Detect Cerebrospinal Fluid Biomarker Candidates in Synucleinopathies.
Lachén-Montes M; González-Morales A; Fernández-Irigoyen J; Santamaría E
Methods Mol Biol; 2019; 2044():273-289. PubMed ID: 31432419
[TBL] [Abstract][Full Text] [Related]
33. The human CSF pain proteome.
Khoonsari PE; Ossipova E; Lengqvist J; Svensson CI; Kosek E; Kadetoff D; Jakobsson PJ; Kultima K; Lampa J
J Proteomics; 2019 Jan; 190():67-76. PubMed ID: 29852297
[TBL] [Abstract][Full Text] [Related]
34. A Proteomic Analysis of Individual and Gender Variations in Normal Human Urine and Cerebrospinal Fluid Using iTRAQ Quantification.
Guo Z; Zhang Y; Zou L; Wang D; Shao C; Wang Y; Sun W; Zhang L
PLoS One; 2015; 10(7):e0133270. PubMed ID: 26222143
[TBL] [Abstract][Full Text] [Related]
35. Mass spectrometry-based analysis of cerebrospinal fluid from arthritis patients-immune-related candidate proteins affected by TNF blocking treatment.
Estelius J; Lengqvist J; Ossipova E; Idborg H; Le Maître E; Andersson MLA; Brundin L; Khademi M; Svenungsson E; Jakobsson PJ; Lampa J
Arthritis Res Ther; 2019 Feb; 21(1):60. PubMed ID: 30770760
[TBL] [Abstract][Full Text] [Related]
36. Photoperiod affects the cerebrospinal fluid proteome: a comparison between short day- and long day-treated ewes.
Teixeira-Gomes AP; Harichaux G; Gennetay D; Skipor J; Thiery JC; Labas V; Dufourny L
Domest Anim Endocrinol; 2015 Oct; 53():1-8. PubMed ID: 26046803
[TBL] [Abstract][Full Text] [Related]
37. Proteome analysis of chick embryonic cerebrospinal fluid.
Parada C; Gato A; Aparicio M; Bueno D
Proteomics; 2006 Jan; 6(1):312-20. PubMed ID: 16287170
[TBL] [Abstract][Full Text] [Related]
38. In Vivo Large-Scale Mapping of Protein Turnover in Human Cerebrospinal Fluid.
Lehmann S; Hirtz C; Vialaret J; Ory M; Combes GG; Corre ML; Badiou S; Cristol JP; Hanon O; Cornillot E; Bauchet L; Gabelle A; Colinge J
Anal Chem; 2019 Dec; 91(24):15500-15508. PubMed ID: 31730336
[TBL] [Abstract][Full Text] [Related]
39. Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis.
Collins MA; An J; Hood BL; Conrads TP; Bowser RP
J Proteome Res; 2015 Nov; 14(11):4486-501. PubMed ID: 26401960
[TBL] [Abstract][Full Text] [Related]
40. Identification of Missing Proteins in Normal Human Cerebrospinal Fluid.
Macron C; Lane L; Núñez Galindo A; Dayon L
J Proteome Res; 2018 Dec; 17(12):4315-4319. PubMed ID: 30106588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
